Proquazone

DB13649

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 278.355
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Proquazone may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Proquazone.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Proquazone.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Proquazone.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Proquazone.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Proquazone.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Proquazone.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Proquazone.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Proquazone.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Proquazone.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Proquazone.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Proquazone.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Proquazone.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Proquazone.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Proquazone.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Proquazone.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Proquazone.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Proquazone.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Proquazone.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Proquazone.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Proquazone.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Proquazone.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Proquazone.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Proquazone.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Proquazone.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Proquazone.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Proquazone.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Proquazone.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Proquazone.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Proquazone.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Proquazone.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Proquazone.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Proquazone.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Proquazone.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Proquazone.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Proquazone.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Proquazone.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Proquazone.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Proquazone.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Proquazone.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Proquazone.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Proquazone.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Proquazone.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Proquazone.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Proquazone.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Proquazone.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Proquazone.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Proquazone.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Proquazone.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Proquazone.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Proquazone.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Proquazone.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Proquazone.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Proquazone.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Proquazone.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Proquazone.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Proquazone.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Proquazone.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Proquazone.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Proquazone.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Proquazone.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Proquazone.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Proquazone.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Proquazone.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Proquazone.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Proquazone.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Proquazone.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Proquazone.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Proquazone.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Proquazone.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Proquazone.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Proquazone.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Proquazone.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Proquazone.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Proquazone.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Proquazone.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Proquazone.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Proquazone.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Proquazone.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Proquazone.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Proquazone.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Proquazone.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Proquazone.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Proquazone.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Proquazone.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Proquazone.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Proquazone.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Proquazone.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Proquazone.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Proquazone.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Proquazone.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Proquazone.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Proquazone.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Proquazone.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Proquazone.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Proquazone.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Proquazone.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Proquazone.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Proquazone.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Proquazone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul